SOURCE BIOSCIENCE UK LIMITED
ActiveCompany no. 04078501 · Private limited company · Incorporated 26 Sep 2000
Company no. 04078501 · Private limited company · Incorporated 26 Sep 2000
Original documents filed with Companies House · 161 filings
17 Sep 2020
Capital
Statement of capital following an allotment of shares on 17 Sep 2020
PDF · 3 pages
7 Sep 2020
Confirmation
Confirmation statement made on 5 Sep 2020 with updates
PDF · 4 pages
2 Apr 2020
Officers
Director's details changed for Mr Russell Steven Wheatcroft on 24 Mar 2020
PDF · 2 pages
2 Mar 2020
Officers
Termination of appointment of Trevor Frank Nolan as a director on 28 Feb 2020
PDF · 1 page
9 Sep 2019
Confirmation
Confirmation statement made on 5 Sep 2019 with updates
PDF · 4 pages
28 Sep 2018
Accounts
Previous accounting period shortened from 31 Dec 2017 to 30 Dec 2017
PDF · 1 page
13 Sep 2018
Confirmation
Confirmation statement made on 5 Sep 2018 with updates
PDF · 4 pages
31 Jul 2018
Ownership
Change of details for Source Bioscience Plc as a person with significant control on 6 Sep 2017
PDF · 2 pages
28 Dec 2017
Officers
Director's details changed for Mr Russell Steven Wheatcroft on 28 Dec 2017
PDF · 2 pages
5 Oct 2017
Officers
Termination of appointment of Michael John Astle as a secretary on 5 Oct 2017
PDF · 1 page
8 Sep 2017
Charge
Registration of charge 040785010005, created on 6 Sep 2017
PDF · 16 pages
Showing 26–50 of 161 filings. Documents open on Companies House in a new tab.
17 Jan 2018
Officers
Appointment of Mr Trevor Frank Nolan as a director on 9 Jan 2018
PDF · 2 pages
17 Jan 2018
Officers
Termination of appointment of Iain Macdonald Chisholm as a director on 2 Jan 2018
PDF · 1 page
5 Sep 2017
Ownership
Change of details for Source Bioscience Plc as a person with significant control on 5 Sep 2017
PDF · 2 pages
5 Sep 2017
Confirmation
Confirmation statement made on 5 Sep 2017 with updates
PDF · 4 pages
24 May 2017
Officers
Director's details changed for Mr Jay Charles Lecoque on 24 May 2017
PDF · 2 pages
12 May 2017
Officers
Termination of appointment of James Douglas Agnew as a director on 12 May 2017
PDF · 1 page